Microbiology 2014-03-01

A putative branched-chain-amino-acid transaminase gene required for HC-toxin biosynthesis and pathogenicity in Cochliobolus carbonum.

Josefina M Villegas, Lorena Valle, Faustino E Morán Vieyra, María R Rintoul, Claudio D Borsarelli, Viviana A Rapisarda

Index: Microbiology 145 ( Pt 12) , 3539-46, (1999)

Full Text: HTML

Abstract

The cyclic tetrapeptide HC-toxin is required for pathogenicity of the filamentous fungus Cochliobolus carbonum on maize. HC-toxin production is controlled by a complex locus, TOX2. The isolation and characterization of a new gene of the TOX2 locus, TOXF, is reported. It is shown that TOXF is specifically required for HC-toxin production and pathogenicity. It is present as two or three copies in all HC-toxin-producing (Tox2+) isolates and is absent in toxin-non-producing strains. The deduced amino acid sequence of TOXF has moderate homology to many known or putative branched-chain-amino-acid transaminases from various species. A strain of C. carbonum with all copies of TOXF disrupted grew normally but lost HC-toxin production and pathogenicity. It is proposed that TOXF has a biosynthetic role in HC-toxin synthesis, perhaps to aminate a precursor of Aeo (2-amino-9,10-epoxi-8-oxodecanoic acid).


Related Compounds

Related Articles:

Expression of 15-lipoxygenase-1 is regulated by histone acetylation in human colorectal carcinoma.

2001-01-01

[Carcinogenesis 22(1) , 187-91, (2001)]

Regulation of cyclic peptide biosynthesis in a plant pathogenic fungus by a novel transcription factor.

2001-11-20

[Proc. Natl. Acad. Sci. U. S. A. 98(24) , 14174-9, (2001)]

An extended physical map of the TOX2 locus of Cochliobolus carbonum required for biosynthesis of HC-toxin.

2002-02-01

[Fungal Genet. Biol. 35(1) , 31-8, (2002)]

Reduced virulence caused by meiotic instability of the TOX2 chromosome of the maize pathogen Cochliobolus carbonum.

2000-01-01

[Mol. Plant Microbe Interact. 13(1) , 80-7, (2000)]

Anti-neuroblastoma activity of Helminthosporium carbonum (HC)-toxin is superior to that of other differentiating compounds in vitro.

2008-06-08

[Cancer Lett. 264(1) , 21-8, (2008)]

More Articles...